In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...

The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

As we age, our vision undergoes natural changes, including difficulty focusing on near objects (presbyopia) and reduced light ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...

The inverted ILM flap technique yields better macular hole closure than ILM peeling for some high myopic macular holes.

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...

A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...

Age-related macular degeneration (AMD) causes progressive vision loss in a large number of elderly people, and no treatment ...

Optegra and Zeiss’s annual CPD event, All Eyes on the Future, was attended by 90 eye care professionals at Conference Aston in Birmingham. The event explored cataract surgery, age-related macular ...

Emerging gene therapy administered through a one-time subretinal injection marks a major milestone for the inherited retinal disease community RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2025 (GLOBE ...